The current paper reveals an overall higher frequency of PSMA expression (scores 1 and 2) (59%) in the current cohort of 704 tumors covering the entire spectrum of biological behavior from benign to malignant tumors of soft tissue and bone, including vascular tumors (Table 1). The gene discussed is FOLH1; the disease is vascular neoplasm.